Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report

Patients with non-small cell lung cancer (NSCLC) harboring anaplastic lymphoma kinase (ALK) gene rearrangements are treated with crizotinib. However, treatment with crizotinib is often discontinued owing to hepatotoxicity. Herein, we report a case of crizotinib-induced liver failure that was success...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiangming, Ni, Kai, Chen, Huijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884431/
https://www.ncbi.nlm.nih.gov/pubmed/36721855
http://dx.doi.org/10.2147/OTT.S393165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884431/
https://www.ncbi.nlm.nih.gov/pubmed/36721855
http://dx.doi.org/10.2147/OTT.S393165

Ejemplares similares